VADUZ, Liechtenstein, Nov. 15, 2024 /PRNewswire/ — RefluxStop™ achieves crucial FDA milestone and leaps forward with strong momentum in both the US and Europe Significant events in the third quarter of 2024 First national RefluxStop™ […]
Tag: Implantica
Implantica submits FDA PMA application Clinical Module 2 for RefluxStop™ for U.S. market approval
VADUZ, Liechtenstein, Nov. 14, 2024 /PRNewswire/ — Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including the unique device RefluxStop™ for the treatment of acid reflux, a treatment […]
Implantica announces highly successful 2024 American Foregut Society meeting where RefluxStop® received remarkable pre-launch market feedback
VADUZ, Liechtenstein, Oct. 10, 2024 /PRNewswire/ — Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, is pleased to report an impressive level of support from a large […]
Implantica welcomes 23 top anti-reflux surgeons from 17 leading centers in the first User meeting in Spain, 1.5 years post country launch
VADUZ, Liechtenstein, Oct. 1, 2024 /PRNewswire/ — Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, announces that the first Spanish User meeting took place over two days […]
Implantica conducts first national RefluxStop™ User meeting with 21 participating surgeons, 1.5 years after launch in Italy
VADUZ, Liechtenstein, Sept. 19, 2024 /PRNewswire/ — Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, had the pleasure to host a regional full day User meeting with […]
